These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 24515096)

  • 1. Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients.
    Dong HY; Xie J; Chen LH; Wang TT; Zhao YR; Dong YL
    Eur J Clin Microbiol Infect Dis; 2014 Jun; 33(6):1029-35. PubMed ID: 24515096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy.
    Niwa T; Suzuki A; Sakakibara S; Kasahara S; Yasuda M; Fukao A; Matsuura K; Goto C; Murakami N; Itoh Y
    Clin Ther; 2009 Oct; 31(10):2126-33. PubMed ID: 19922883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients.
    Pea F; Viale P; Cojutti P; Del Pin B; Zamparini E; Furlanut M
    J Antimicrob Chemother; 2012 Aug; 67(8):2034-42. PubMed ID: 22553142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of the risk factors for linezolid-induced thrombocytopenia in adult Japanese patients.
    Hirano R; Sakamoto Y; Tachibana N; Ohnishi M
    Int J Clin Pharm; 2014 Aug; 36(4):795-9. PubMed ID: 24913359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors associated with the development of thrombocytopenia in patients who received linezolid therapy.
    Takahashi Y; Takesue Y; Nakajima K; Ichiki K; Tsuchida T; Tatsumi S; Ishihara M; Ikeuchi H; Uchino M
    J Infect Chemother; 2011 Jun; 17(3):382-7. PubMed ID: 21127934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients.
    Matsumoto K; Shigemi A; Takeshita A; Watanabe E; Yokoyama Y; Ikawa K; Morikawa N; Takeda Y
    Int J Antimicrob Agents; 2014 Sep; 44(3):242-7. PubMed ID: 25108880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use.
    Nasraway SA; Shorr AF; Kuter DJ; O'Grady N; Le VH; Cammarata SK
    Clin Infect Dis; 2003 Dec; 37(12):1609-16. PubMed ID: 14689341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linezolid-associated thrombocytopenia.
    Lam S
    Consult Pharm; 2012 Jul; 27(7):504-8. PubMed ID: 22910131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic liver disease increases the risk of linezolid-related thrombocytopenia in methicillin-resistant Staphylococcus aureus-infected patients after digestive surgery.
    Ikuta S; Tanimura K; Yasui C; Aihara T; Yoshie H; Iida H; Beppu N; Kurimoto A; Yanagi H; Mitsunobu M; Yamanaka N
    J Infect Chemother; 2011 Jun; 17(3):388-91. PubMed ID: 21161560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of vancomycin or linezolid therapy on development of renal dysfunction and thrombocytopenia in Japanese patients.
    Fujii S; Takahashi S; Makino S; Kunimoto Y; Nakata H; Noda N; Sakurai K; Miyamoto A
    Chemotherapy; 2013; 59(5):319-24. PubMed ID: 24480883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia.
    Nukui Y; Hatakeyama S; Okamoto K; Yamamoto T; Hisaka A; Suzuki H; Yata N; Yotsuyanagi H; Moriya K
    J Antimicrob Chemother; 2013 Sep; 68(9):2128-33. PubMed ID: 23625638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linezolid more efficacious than vancomycin to eradicate infecting organism in critically ill patients with Gram-positive infections.
    Sirvent JM; Piñeiro L; de la Torre M; Motjé M; de Batlle J; Bonet A
    Rev Esp Quimioter; 2010 Mar; 23(1):27-35. PubMed ID: 20232021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience of linezolid in bone marrow transplantation patients.
    Hogan HL; Hachem RY; Neuhauser M; Raad II; Coyle E
    J Pharm Pract; 2010 Aug; 23(4):352-7. PubMed ID: 21507835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linezolid: low pre-treatment platelet values could increase the risk of thrombocytopenia.
    Grau S; Morales-Molina JA; Mateu-de Antonio J; Marín-Casino M; Alvarez-Lerma F
    J Antimicrob Chemother; 2005 Aug; 56(2):440-1. PubMed ID: 15956097
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk factors for a low linezolid trough plasma concentration in acute infections.
    Morata L; Cuesta M; Rojas JF; Rodriguez S; Brunet M; Casals G; Cobos N; Hernandez C; Martínez JA; Mensa J; Soriano A
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1913-7. PubMed ID: 23403416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factor analysis for linezolid-associated thrombocytopenia in critically ill patients.
    Cazavet J; Bounes FV; Ruiz S; Seguin T; Crognier L; Rouget A; Fourcade O; Minville V; Conil JM; Georges B
    Eur J Clin Microbiol Infect Dis; 2020 Mar; 39(3):527-538. PubMed ID: 31853741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Case report: severe thrombocytopenia].
    Sakka SG; Schürmann A; Knüttgen D; Wappler F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Apr; 44(4):242-5. PubMed ID: 19367527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetic and pharmacodynamic analysis of linezolid and a hematologic side effect, thrombocytopenia, in Japanese patients.
    Sasaki T; Takane H; Ogawa K; Isagawa S; Hirota T; Higuchi S; Horii T; Otsubo K; Ieiri I
    Antimicrob Agents Chemother; 2011 May; 55(5):1867-73. PubMed ID: 21357301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative evaluation of adverse platelet outcomes among Veterans' Affairs patients receiving linezolid or vancomycin.
    Patel N; VanDeWall H; Tristani L; Rivera A; Woo B; Dihmess A; Li HK; Smith R; Lodise TP
    J Antimicrob Chemother; 2012 Mar; 67(3):727-35. PubMed ID: 22174041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of linezolid-associated thrombocytopenia by the dose adjustment based on the risk factors such as basal platelet count and body weight.
    Niwa T; Watanabe T; Suzuki A; Ohmori T; Tsuchiya M; Suzuki T; Ohta H; Murakami N; Itoh Y
    Diagn Microbiol Infect Dis; 2014 May; 79(1):93-7. PubMed ID: 24565849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.